InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,728.80
(
0.41%
)
US TECH 100
19,528.00
(
0.90%
)
Dow Jones
42,052.19
(
0.69%
)
Brent Oil
72.91
(
0.00%
)
Bitcoin
69,618.94
(
0.20%
)
Post# of 6186
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

docj

Send PM Follow Ignore
Followers 21
Posts 2490
Boards Moderated 1
Alias Born 09/15/2011

docj

Re: bentleyt post# 6003

Wednesday, 05/17/2023 7:49:40 AM

Wednesday, May 17, 2023 7:49:40 AM

Post# of 6186
Given Altitrade Partners deep research I hope they/you are right. My personal preference, as well as my families, would be to see progress being made and a private buyout. This would be so much less complicated for everyone.

I wonder if Altitrade Partners has done a valuation recently. It has been a while. Has the market for Generx changed? Any other therapies catching up?

I'd also like to understand what the situation with Nostrum is at this time. Why did they take such a large interest in CRXM only to have Generx sit on a shelf?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up